Featured News
AMPEL BioSolutions’ Precision Medicine Breakthrough Predicts Drug Options with RNA Analytics & Machine Learning
AMPEL on Bloomberg Markets
Lupus, coronary artery disease share genetic risk factors; data may lead to early testing
Local company unveils blood test to find treatments for chronic pain
Local company unveils blood test to find treatments for chronic pain
AMPEL BioSolutions Enters MDx Market With Lupus, Dermatology Gene Expression Assays
Virginia Catalyst Announces AMPEL as Grant Round 14 Awardee
COMPANY
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
PLATFORM
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
PRODUCTS
New test may guide treatment of common skin diseases
Dermatologists routinely do skin biopsies to figure out what’s wrong with their patients. They study tissue under a microscope – looking at the structure of cells, but a Charlottesville company says doctors could treat disease more precisely by looking at genetics.
AMPEL BioSolutions’ Machine Learning Breakthrough Predicts Chronic Disease Flares from a Blood Sample
Machine Learning Approaches to Predict Lupus Disease Activity from Gene Expression Data
The integration of gene expression data to predict systemic lupus erythematosus (SLE) disease activity is a significant challenge because of the high degree of heterogeneity among patients and study cohorts, especially those collected on different microarray...
Local BioTech company creates test to predict severity of COVID cases
A Charlottesville-based company is leading the way in the fight against COVID. The biotech company, AMPEL BioSolutions, says it created a test capable of predicting which patients may experience severe cases of the virus.
Doctors and patients monitor Lupus with mobile app
CLICK TO VIEW ORIGINAL ARTICLE > by Josh Mandell A Charlottesville company is helping to lead a global scientific effort to better understand and treat lupus, an autoimmune disease sometimes called “the cruel mystery.” AMPEL Bio Solutions, a biomedical...
Trial of LuPRO mobile app predicts Lupus flares
CLICK TO VIEW ORIGINAL ARTICLE > BY KATIE O'CONNOR, Richmond Times-Dispatch In 50 years, only one treatment was approved by the U.S. Food and Drug Administration to treat lupus, an autoimmune disease in which a person’s immune system attacks their healthy organs...
PARTNERS
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.